Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in Mice.

Vollaire J, Machuca-Gayet I, Lavaud J, Bellanger A, Bouazza L, El Moghrabi S, Treilleux I, Coll JL, Peyruchaud O, Josserand V, Cohen PA.

Front Pharmacol. 2019 Jun 19;10:667. doi: 10.3389/fphar.2019.00667. eCollection 2019.

2.

Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer.

Poulard C, Jacquemetton J, Trédan O, Cohen PA, Vendrell J, Ghayad SE, Treilleux I, Marangoni E, Le Romancer M.

Int J Mol Sci. 2019 Jun 5;20(11). pii: E2773. doi: 10.3390/ijms20112773.

3.

The ZNF217 Biomarker Predicts Low- and High-Risk Oncotype DX® Recurrence Score in ER-Positive Invasive Breast Cancers.

Cohen PA, Loudig O, Liu C, Albanese J, Fineberg S.

Front Pharmacol. 2019 May 28;10:524. doi: 10.3389/fphar.2019.00524. eCollection 2019.

4.

The Opportunity of CBD - Reforming the Law.

Cohen PA, Sharfstein J.

N Engl J Med. 2019 Jun 12. doi: 10.1056/NEJMp1906409. [Epub ahead of print] No abstract available.

PMID:
31189033
5.

Promoting physical activity in regional and remote cancer survivors (PPARCS) using wearables and health coaching: randomised controlled trial protocol.

Hardcastle SJ, Hince D, Jiménez-Castuera R, Boyle T, Cavalheri V, Makin G, Tan P, Salfinger S, Tan J, Mohan GR, Levitt M, Cohen PA, Saunders C, Platell C.

BMJ Open. 2019 May 24;9(5):e028369. doi: 10.1136/bmjopen-2018-028369.

6.

Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data.

Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S, Brockbank EC, Bosse T, de Azevedo Focchi GR, Ganesan R, Glasspool RM, Howitt BE, Kim HS, Lee JY, Le ND, Lockley M, Manchanda R, Mandalia T, McCluggage WG, McNeish I, Midha D, Srinivasan R, Tan YY, van der Griend R, Yunokawa M, Zannoni GF; HGSC CRS Collaborative Network (Supplementary 1), Singh N.

Gynecol Oncol. 2019 May 19. pii: S0090-8258(19)31181-3. doi: 10.1016/j.ygyno.2019.04.679. [Epub ahead of print] Review.

7.

Screening for sexual health concerns in survivors of gynecological cancer.

Roberts K, Chong T, Hollands E, Tan J, Mohan GRKA, Cohen PA.

Support Care Cancer. 2019 May 18. doi: 10.1007/s00520-019-04872-4. [Epub ahead of print]

PMID:
31104133
8.

Uptake of testing for germline BRCA mutations in patients with non-mucinous epithelial ovarian cancers in Western Australia: a comparison of different genetic counseling methods.

Stearnes G, Nichols CB, Schofield L, O'Sullivan S, Pachter N, Cohen PA.

Int J Gynecol Cancer. 2019 Jul;29(6):1038-1042. doi: 10.1136/ijgc-2019-000389. Epub 2019 May 17.

PMID:
31101686
9.

Measuring response to neoadjuvant chemotherapy in high-grade serous tubo-ovarian carcinoma: an analysis of the correlation between CT imaging and chemotherapy response score.

McNulty M, Das A, Cohen PA, Dean A.

Int J Gynecol Cancer. 2019 May 15. pii: ijgc-2019-000222. doi: 10.1136/ijgc-2019-000222. [Epub ahead of print]

PMID:
31097511
10.

A randomized controlled trial of WATAAP to promote physical activity in colorectal and endometrial cancer survivors.

Maxwell-Smith C, Hince D, Cohen PA, Bulsara MK, Boyle T, Platell C, Tan P, Levitt M, Salama P, Tan J, Salfinger S, Makin G, Mohan GRKA, Jiménez-Castuera R, Hardcastle SJ.

Psychooncology. 2019 Jul;28(7):1420-1429. doi: 10.1002/pon.5090. Epub 2019 Apr 26.

PMID:
30980691
11.

Evaluating ZNF217 mRNA Expression Levels as a Predictor of Response to Endocrine Therapy in ER+ Breast Cancer.

Vendrell JA, Solassol J, Győrffy B, Vilquin P, Jarlier M, Donini CF, Gamba L, Maudelonde T, Rouanet P, Cohen PA.

Front Pharmacol. 2019 Jan 25;9:1581. doi: 10.3389/fphar.2018.01581. eCollection 2018.

12.

Clinical and molecular classification of vulvar squamous pre-cancers.

Cohen PA, Anderson L, Eva L, Scurry J.

Int J Gynecol Cancer. 2019 May;29(4):821-828. doi: 10.1136/ijgc-2018-000135. Epub 2019 Feb 7.

PMID:
30737358
13.

Probiotic Safety-Reasonable Certainty of No Harm-Reply.

Cohen PA.

JAMA Intern Med. 2019 Feb 1;179(2):276-277. doi: 10.1001/jamainternmed.2018.7492. No abstract available.

PMID:
30715115
14.

The FDA and Adulterated Supplements-Dereliction of Duty.

Cohen PA.

JAMA Netw Open. 2018 Oct 5;1(6):e183329. doi: 10.1001/jamanetworkopen.2018.3329. No abstract available.

PMID:
30646231
15.

Cervical cancer.

Cohen PA, Jhingran A, Oaknin A, Denny L.

Lancet. 2019 Jan 12;393(10167):169-182. doi: 10.1016/S0140-6736(18)32470-X. Review.

PMID:
30638582
16.

Acceptability and utility of, and preference for wearable activity trackers amongst non-metropolitan cancer survivors.

Hardcastle SJ, Galliott M, Lynch BM, Nguyen NH, Cohen PA, Mohan GR, Johansen NJ, Saunders C.

PLoS One. 2018 Dec 31;13(12):e0210039. doi: 10.1371/journal.pone.0210039. eCollection 2018.

17.

Wearable Activity Technology And Action-Planning (WATAAP) to promote physical activity in cancer survivors: Randomised controlled trial protocol.

Maxwell-Smith C, Cohen PA, Platell C, Tan P, Levitt M, Salama P, Makin GB, Tan J, Salfinger S, Kader Ali Mohan GR, Kane RT, Hince D, Jiménez-Castuera R, Hardcastle SJ.

Int J Clin Health Psychol. 2018 May-Aug;18(2):124-132. doi: 10.1016/j.ijchp.2018.03.003. Epub 2018 Apr 14.

18.

Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review.

Binju M, Padilla MA, Singomat T, Kaur P, Suryo Rahmanto Y, Cohen PA, Yu Y.

Biochim Biophys Acta Gen Subj. 2019 Feb;1863(2):371-378. doi: 10.1016/j.bbagen.2018.11.005. Epub 2018 Nov 10. Review.

PMID:
30423357
19.

Prohibited Stimulants in Dietary Supplements After Enforcement Action by the US Food and Drug Administration.

Cohen PA, Wen A, Gerona R.

JAMA Intern Med. 2018 Dec 1;178(12):1721-1723. doi: 10.1001/jamainternmed.2018.4846. No abstract available.

PMID:
30422217
20.

RANZCOG Fellows' adherence to guidelines following cytological prediction of cervical adenocarcinoma-in-situ: Cause for concern?

Powell A, Cohen PA, Spilsbury K, Steel N, Blomfield P.

Aust N Z J Obstet Gynaecol. 2019 Apr;59(2):294-300. doi: 10.1111/ajo.12886. Epub 2018 Oct 4.

PMID:
30284744
21.

Probiotic Safety-No Guarantees.

Cohen PA.

JAMA Intern Med. 2018 Dec 1;178(12):1577-1578. doi: 10.1001/jamainternmed.2018.5403. No abstract available.

PMID:
30242393
22.

The stimulant higenamine in weight loss and sports supplements.

Cohen PA, Travis JC, Keizers PHJ, Boyer FE, Venhuis BJ.

Clin Toxicol (Phila). 2019 Feb;57(2):125-130. doi: 10.1080/15563650.2018.1497171. Epub 2018 Sep 6.

PMID:
30188222
23.

'Eminence based medicine' and the Goldilocks principle: Authors' reply to 'Working hours of obstetrics and gynaecology trainees in Australia and New Zealand'.

Acton JN, Tucker PE, Bulsara MK, Cohen PA.

Aust N Z J Obstet Gynaecol. 2018 Aug;58(4):E9-E10. doi: 10.1111/ajo.12843. Epub 2018 Jun 27. No abstract available.

24.

Knowledge, attitudes, and practice of oncologists and oncology health care providers in promoting physical activity to cancer survivors: an international survey.

Hardcastle SJ, Kane R, Chivers P, Hince D, Dean A, Higgs D, Cohen PA.

Support Care Cancer. 2018 Nov;26(11):3711-3719. doi: 10.1007/s00520-018-4230-1. Epub 2018 May 8.

PMID:
29740694
25.

Health-related quality of life and pelvic floor dysfunction in advanced-stage ovarian cancer survivors: associations with objective activity behaviors and physiological characteristics.

Schofield C, Newton RU, Cohen PA, Galvão DA, McVeigh JA, Mohan GR, Tan J, Salfinger SG, Straker LM, Peddle-McIntyre CJ.

Support Care Cancer. 2018 Jul;26(7):2239-2246. doi: 10.1007/s00520-018-4069-5. Epub 2018 Feb 1.

PMID:
29392481
26.

Reply to S.C. Adams et al, C. Lopez et al, and R.U. Newton et al.

Hardcastle SJ, Cohen PA.

J Clin Oncol. 2018 Mar 20;36(9):928-930. doi: 10.1200/JCO.2017.76.8218. Epub 2018 Jan 26. No abstract available.

PMID:
29373095
27.

Activity Behaviors and Physiological Characteristics of Women With Advanced-Stage Ovarian Cancer: A Preliminary Cross-sectional Investigation.

Schofield C, Newton RU, Cohen PA, Galvão DA, McVeigh JA, Hart NH, Mohan GR, Tan J, Salfinger SG, Straker LM, Peddle-McIntyre CJ.

Int J Gynecol Cancer. 2018 Mar;28(3):604-613. doi: 10.1097/IGC.0000000000001197.

PMID:
29369120
28.

Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.

Shaw J, Bulsara C, Cohen PA, Gryta M, Nichols CB, Schofield L, O'Sullivan S, Pachter N, Hardcastle SJ.

Patient Educ Couns. 2018 May;101(5):938-944. doi: 10.1016/j.pec.2017.12.011. Epub 2017 Dec 12.

PMID:
29273311
29.

Advanced Training of Gynecologic Surgeons and Incidence of Intraoperative Complications after Total Laparoscopic Hysterectomy: A Retrospective Study of More Than 2000 Cases at a Single Institution.

McDonnell RM, Hollingworth JL, Chivers P, Cohen PA, Salfinger SG.

J Minim Invasive Gynecol. 2018 Jul - Aug;25(5):810-815. doi: 10.1016/j.jmig.2017.12.005. Epub 2017 Dec 15.

PMID:
29253636
30.

Do Groin Drains Reduce Postoperative Morbidity in Women Undergoing Inguinofemoral Lymphadenectomy for Vulvar Cancer?

Pontre J, Harding J, Chivers P, Loughlin L, Leung Y, Salfinger SG, Tan J, Mohan GR, Cohen PA.

Int J Gynecol Cancer. 2018 Jan;28(1):183-187. doi: 10.1097/IGC.0000000000001146.

PMID:
29252926
31.

Outcomes in women undergoing robotic-assisted laparoscopic hysterectomy compared to conventional laparoscopic hysterectomy at a tertiary hospital in Western Australia.

Rajadurai VA, Tan J, Salfinger SG, Cohen PA.

Aust N Z J Obstet Gynaecol. 2018 Aug;58(4):443-448. doi: 10.1111/ajo.12749. Epub 2017 Nov 23.

PMID:
29168558
32.

Snowball Earth climate dynamics and Cryogenian geology-geobiology.

Hoffman PF, Abbot DS, Ashkenazy Y, Benn DI, Brocks JJ, Cohen PA, Cox GM, Creveling JR, Donnadieu Y, Erwin DH, Fairchild IJ, Ferreira D, Goodman JC, Halverson GP, Jansen MF, Le Hir G, Love GD, Macdonald FA, Maloof AC, Partin CA, Ramstein G, Rose BEJ, Rose CV, Sadler PM, Tziperman E, Voigt A, Warren SG.

Sci Adv. 2017 Nov 8;3(11):e1600983. doi: 10.1126/sciadv.1600983. eCollection 2017 Nov.

33.

Questioning the value of margin status in treated cervical precancer.

Cohen PA.

Lancet Oncol. 2017 Dec;18(12):1565-1566. doi: 10.1016/S1470-2045(17)30839-2. Epub 2017 Nov 7. No abstract available. Erratum in: Lancet Oncol. 2018 Jan;19(1):e8.

PMID:
29126707
34.

Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide.

Supekar NT, Lakshminarayanan V, Capicciotti CJ, Sirohiwal A, Madsen CS, Wolfert MA, Cohen PA, Gendler SJ, Boons GJ.

Chembiochem. 2018 Jan 18;19(2):121-125. doi: 10.1002/cbic.201700424. Epub 2017 Nov 30.

35.

Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA).

Cohen PA, Travis JC, Keizers PHJ, Deuster P, Venhuis BJ.

Clin Toxicol (Phila). 2018 Jun;56(6):421-426. doi: 10.1080/15563650.2017.1398328. Epub 2017 Nov 8.

PMID:
29115866
36.

Scientific Trials-In the Laboratories, Not the Courts.

Bagley N, Carroll AE, Cohen PA.

JAMA Intern Med. 2018 Jan 1;178(1):7-8. doi: 10.1001/jamainternmed.2017.5730. Review. No abstract available.

PMID:
29114742
37.

Factors influencing non-participation in an exercise program and attitudes towards physical activity amongst cancer survivors.

Hardcastle SJ, Maxwell-Smith C, Kamarova S, Lamb S, Millar L, Cohen PA.

Support Care Cancer. 2018 Apr;26(4):1289-1295. doi: 10.1007/s00520-017-3952-9. Epub 2017 Oct 31.

PMID:
29090387
38.

Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer.

Garsed DW, Alsop K, Fereday S, Emmanuel C, Kennedy CJ, Etemadmoghadam D, Gao B, Gebski V, Garès V, Christie EL, Wouters MCA, Milne K, George J, Patch AM, Li J, Arnau GM, Semple T, Gadipally SR, Chiew YE, Hendley J, Mikeska T, Zapparoli GV, Amarasinghe K, Grimmond SM, Pearson JV, Waddell N, Hung J, Stewart CJR, Sharma R, Allan PE, Rambau PF, McNally O, Mileshkin L, Hamilton A, Ananda S, Grossi M, Cohen PA, Leung YC, Rome RM, Beale P, Blomfield P, Friedlander M, Brand A, Dobrovic A, Köbel M, Harnett P, Nelson BH, Bowtell DDL, deFazio A; Nadia Traficante, for the Australian Ovarian Cancer Study Group.

Clin Cancer Res. 2018 Feb 1;24(3):569-580. doi: 10.1158/1078-0432.CCR-17-1621. Epub 2017 Oct 23.

39.

A Physiological Profile of Ovarian Cancer Survivors to Inform Tailored Exercise Interventions and the Development of Exercise Oncology Guidelines.

Schofield C, Newton RU, Galvão DA, Cohen PA, Peddle-McIntyre CJ.

Int J Gynecol Cancer. 2017 Sep;27(7):1560-1567. doi: 10.1097/IGC.0000000000001044. Review.

PMID:
29036032
40.

Effective Physical Activity Promotion to Survivors of Cancer Is Likely to Be Home Based and to Require Oncologist Participation.

Hardcastle SJ, Cohen PA.

J Clin Oncol. 2017 Nov 10;35(32):3635-3637. doi: 10.1200/JCO.2017.74.6032. Epub 2017 Sep 15. No abstract available.

PMID:
28915086
41.

A Physiological Profile of Ovarian Cancer Survivors to Inform Tailored Exercise Interventions and the Development of Exercise Oncology Guidelines.

Schofield C, Newton RU, Galvão DA, Cohen PA, Peddle-McIntyre CJ.

Int J Gynecol Cancer. 2017 Sep;27(7):1560-1567. doi: 10.1097/IGC.0000000000001044. Review.

PMID:
30814246
42.

Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot study.

Cohen PA, Brand A, Sykes P, Wrede DCH, McNally O, Eva L, Rao A, Campion M, Stockler M, Powell A, Codde J, Bulsara MK, Anderson L, Leung Y, Farrell L, Stoyles P.

BMJ Open. 2017 Aug 28;7(8):e017576. doi: 10.1136/bmjopen-2017-017576.

43.

Controlled hydroxyapatite biomineralization in an ~810 million-year-old unicellular eukaryote.

Cohen PA, Strauss JV, Rooney AD, Sharma M, Tosca N.

Sci Adv. 2017 Jun 28;3(6):e1700095. doi: 10.1126/sciadv.1700095. eCollection 2017 Jun.

44.

Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment.

Weinstein AM, Chen L, Brzana EA, Patil PR, Taylor JL, Fabian KL, Wallace CT, Jones SD, Watkins SC, Lu B, Stroncek DF, Denning TL, Fu YX, Cohen PA, Storkus WJ.

Oncoimmunology. 2017 Apr 28;6(6):e1322238. doi: 10.1080/2162402X.2017.1322238. eCollection 2017.

45.

Risk of persistent or recurrent cervical neoplasia in patients with 'pure' adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intra-epithelial neoplasia grades 2 and 3 (CIN 2/3)): a population-based study.

Codde E, Munro A, Stewart C, Spilsbury K, Bowen S, Codde J, Steel N, Leung Y, Tan J, Salfinger SG, Mohan GR, Cohen PA.

BJOG. 2018 Jan;125(1):74-79. doi: 10.1111/1471-0528.14808. Epub 2017 Aug 2.

46.

Variability in strength of red yeast rice supplements purchased from mainstream retailers.

Cohen PA, Avula B, Khan IA.

Eur J Prev Cardiol. 2017 Sep;24(13):1431-1434. doi: 10.1177/2047487317715714. Epub 2017 Jun 23.

PMID:
28641460
47.

Managing menopausal symptoms after breast cancer - A multidisciplinary approach.

Cohen PA, Brennan A, Marino JL, Saunders CM, Hickey M.

Maturitas. 2017 Nov;105:4-7. doi: 10.1016/j.maturitas.2017.04.013. Epub 2017 Apr 22. Review.

PMID:
28473176
48.

Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian Carcinoma.

Coghlan E, Meniawy TM, Munro A, Bulsara M, Stewart CJ, Tan A, Koay ME, MaGee D, Codde J, Tan J, Salfinger SG, Mohan GR, Leung Y, Nichols CB, Cohen PA.

Int J Gynecol Cancer. 2017 May;27(4):708-713. doi: 10.1097/IGC.0000000000000945.

PMID:
30814178
49.

Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian Carcinoma.

Coghlan E, Meniawy TM, Munro A, Bulsara M, Stewart CJ, Tan A, Koay MHE, MaGee D, Codde J, Tan J, Salfinger SG, Mohan GR, Leung Y, Nichols CB, Cohen PA.

Int J Gynecol Cancer. 2017 May;27(4):708-713. doi: 10.1097/IGC.0000000000000945.

PMID:
28441251
50.

Fatigue and training of obstetrics and gynaecology trainees in Australia and New Zealand.

Tucker PE, Cohen PA, Bulsara MK, Acton J.

Aust N Z J Obstet Gynaecol. 2017 Oct;57(5):502-507. doi: 10.1111/ajo.12604. Epub 2017 Mar 26.

PMID:
28345217

Supplemental Content

Loading ...
Support Center